In vivo molecular targeted radiotherapy
2005
In Vivo Molecular Targeted Radiotherapy
publication
Evidence: moderate
Author Information
Author(s): Perkins AC
Primary Institution: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
Conclusion
Molecular targeted radionuclide therapy shows promise for future cancer treatments, particularly with the development of new therapeutic agents.
Supporting Evidence
- Radionuclide therapy has been used for over half a century with significant clinical benefits.
- 131I-sodium iodide is a well-established treatment for thyroid cancer.
- New therapeutic agents are being developed to improve targeting and reduce side effects.
Takeaway
This study talks about using special radioactive medicines to treat cancer by targeting the bad cells while leaving the good ones alone.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website